CV Sciences (CVSI) Non Operating Income (2014 - 2025)
CV Sciences' (CVSI) quarterly Non Operating Income came in at $395000.0 in Q4 2025, up 520.21% year-on-year from $63687.8 in Q4 2024, and up 469.16% quarter-over-quarter from -$107000.0 in Q3 2025.
CV Sciences (CVSI) Non Operating Income (2014 - 2025) Analysis & Trends
CV Sciences has disclosed Non Operating Income across 9 years of filings, most recently posting $395000.0 for Q4 2025.
- Non Operating Income for Q4 2025 came in at $395000.0, up 520.21% year-over-year; the trailing twelve-month figure through Dec 2025 was $7000.0 (up 103.3% YoY), and the FY2025 annual result was $7000.0, up 103.3% from the prior year.
- Non Operating Income came in at $395000.0 for Q4 2025 at CV Sciences, up from -$107000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $395000.0 in Q4 2025 to a low of -$336000.0 in Q2 2022.
- The 4-year median for Non Operating Income is -$107000.0 (2025), against an average of -$87200.0.
- Peak annual rise in Non Operating Income reached 520.21% in 2025, while the deepest fall reached 12900.0% in 2025.
- CV Sciences' Non Operating Income stood at -$237000.0 in 2022, then surged by 104.64% to $11000.0 in 2023, then plunged by 954.55% to -$94000.0 in 2024, then soared by 520.21% to $395000.0 in 2025.
- The last three Non Operating Income figures came in at $395000.0 (Q4 2025), -$107000.0 (Q3 2025), and -$130000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 5.71 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -23.23 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | -107,000.00 |
| Jun 30, 2025 | -130,000.00 |
| Mar 31, 2025 | -151,000.00 |
| Dec 31, 2024 | -94,000.00 |
| Sep 30, 2024 | -115,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -209,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | -237,000.00 |
| Sep 30, 2022 | -266,000.00 |
| Jun 30, 2022 | -336,000.00 |
| Dec 31, 2018 | 150,386.00 |
| Sep 30, 2018 | -30,556.00 |
| Jun 30, 2018 | -71,558.00 |
| Mar 31, 2018 | -4.89 Mn |
| Dec 31, 2017 | 14.28 Mn |